Literature DB >> 20338472

Establishment of a Radiogenomics Consortium.

Catharine West1, Barry S Rosenstein, Jan Alsner, David Azria, Gillian Barnett, Adrian Begg, Søren Bentzen, Neil Burnet, Jenny Chang-Claude, Eric Chuang, Charlotte Coles, Kim De Ruyck, Dirk De Ruysscher, Alison Dunning, Rebecca Elliott, Laura Fachal, Janet Hall, Karin Haustermans, Carsten Herskind, Tobias Hoelscher, Takashi Imai, Mayumi Iwakawa, Don Jones, Cecilia Kulich, Jan-Hans Langendijk, Peter O'Neils, Mahmut Ozsahin, Matthew Parliament, Andrzej Polanski, Barry Rosenstein, Daniela Seminara, Paul Symonds, Chris Talbot, Hubert Thierens, Ana Vega, Catherine West, John Yarnold.   

Abstract

Mesh：

Year:  2010        PMID： 20338472     DOI： 10.1016/j.ijrobp.2009.12.017

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  50 in total

1.  Predicting toxicity from radiation therapy--it's genetic, right?

Authors:  Chris R Kelsey; Barry S Rosenstein; Lawrence B Marks
Journal:  Cancer       Date:  2011-12-05       Impact factor: 6.860

2.  Developing Predictive or Prognostic Biomarkers for Charged Particle Radiotherapy.

Authors:  Michael D Story; Jing Wang
Journal:  Int J Part Ther       Date:  2018

3.  Association between SNPs in defined functional pathways and risk of early or late toxicity as well as individual radiosensitivity.

Authors:  Sebastian Reuther; Silke Szymczak; Annette Raabe; Kerstin Borgmann; Andreas Ziegler; Cordula Petersen; Ekkehard Dikomey; Ulrike Hoeller
Journal:  Strahlenther Onkol       Date:  2014-08-26       Impact factor: 3.621

Review 4.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

Review 5.  Evolution of advanced technologies in prostate cancer radiotherapy.

Authors:  Nicholas G Zaorsky; Amy S Harrison; Edouard J Trabulsi; Leonard G Gomella; Timothy N Showalter; Mark D Hurwitz; Adam P Dicker; Robert B Den
Journal:  Nat Rev Urol       Date:  2013-09-10       Impact factor: 14.432

6.  Molecular biomarkers in the decision of treatment of cervical carcinoma patients.

Authors:  A Valenciano; L A Henríquez-Hernández; M Lloret; B Pinar; P C Lara
Journal:  Clin Transl Oncol       Date:  2013-02-22       Impact factor: 3.405

Review 7.  New biological markers in the decision of treatment of head and neck cancer patients.

Authors:  A Valenciano; L A Henríquez-Hernández; M Lloret; B Pinar; P C Lara
Journal:  Clin Transl Oncol       Date:  2014-07-01       Impact factor: 3.405

Review 8.  The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.

Authors:  Sarah L Kerns; Suman Kundu; Jung Hun Oh; Sandeep K Singhal; Michelle Janelsins; Lois B Travis; Joseph O Deasy; A Cecile J E Janssens; Harry Ostrer; Matthew Parliament; Nawaid Usmani; Barry S Rosenstein
Journal:  Semin Radiat Oncol       Date:  2015-05-15       Impact factor: 5.934

Review 9.  Collaborative cancer epidemiology in the 21st century: the model of cancer consortia.

Authors:  Michael R Burgio; John P A Ioannidis; Brett M Kaminski; Eric Derycke; Scott Rogers; Muin J Khoury; Daniela Seminara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

10.  Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Authors:  Christian Nicolaj Andreassen; Barry S Rosenstein; Sarah L Kerns; Harry Ostrer; Dirk De Ruysscher; Jamie A Cesaretti; Gillian C Barnett; Alison M Dunning; Leila Dorling; Catharine M L West; Neil G Burnet; Rebecca Elliott; Charlotte Coles; Emma Hall; Laura Fachal; Ana Vega; Antonio Gómez-Caamaño; Christopher J Talbot; R Paul Symonds; Kim De Ruyck; Hubert Thierens; Piet Ost; Jenny Chang-Claude; Petra Seibold; Odilia Popanda; Marie Overgaard; David Dearnaley; Matthew R Sydes; David Azria; Christine Anne Koch; Matthew Parliament; Michael Blackshaw; Michael Sia; Maria J Fuentes-Raspall; Teresa Ramon Y Cajal; Agustin Barnadas; Danny Vesprini; Sara Gutiérrez-Enríquez; Meritxell Mollà; Orland Díez; John R Yarnold; Jens Overgaard; Søren M Bentzen; Jan Alsner
Journal:  Radiother Oncol       Date:  2016-07-18       Impact factor: 6.280
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.